Catégories
Traitements innovants en toxicomanie

SPECTRE Project

Modulation of ∆9-tetrahydrocannabinol acute psychoactive effects by ranging doses of cannabidiol in healthy, occasional cannabis users: a controlled, triple blind, randomized, cross-over study

Duration

20 months

Recruitment

Coming soon in 2023

Participants

Aged between 21 and 49

Catégories
Traitements innovants en toxicomanie

CANNABINOIDS studies

INGESTED cannabidiol study:
Approximately 7h/ visit. Monetary compensation proportional to the duration.

Recruitment:
Ended in summer 2023

Participants invited:
Healthy, between the ages of 21 and 65, have used cannabis at least once in your life and are currently an occasional cannabis user.

Your role:
Attend a visit to evaluate your eligibility, take blood samples, complete questionnaires, perform procedures specific to the study project, and consume cannabidiol on site as directed.